Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 19.88B | 20.00B | 19.42B | 17.47B | 14.44B | 13.63B |
Gross Profit | 6.32B | 6.41B | 5.96B | 5.29B | 3.55B | 2.70B |
EBITDA | 2.95B | 3.36B | 3.07B | 2.98B | 1.57B | 1.11B |
Net Income | 1.08B | 1.09B | 1.06B | 897.87M | -434.38M | -972.79M |
Balance Sheet | ||||||
Total Assets | 56.49B | 56.42B | 56.67B | 56.79B | 56.69B | 57.46B |
Cash, Cash Equivalents and Short-Term Investments | 3.00B | 2.66B | 2.71B | 2.49B | 2.52B | 2.44B |
Total Debt | 26.33B | 26.68B | 27.76B | 29.48B | 30.66B | 31.53B |
Total Liabilities | 37.54B | 37.39B | 38.58B | 39.80B | 40.42B | 40.82B |
Stockholders Equity | 18.96B | 19.03B | 18.09B | 16.99B | 16.27B | 16.63B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.56B | 2.06B | 1.32B | 1.00B | -2.46B |
Operating Cash Flow | 0.00 | 2.57B | 2.88B | 2.68B | 2.14B | 509.02M |
Investing Cash Flow | 0.00 | -1.19B | -849.79M | -1.45B | -1.21B | -3.12B |
Financing Cash Flow | 0.00 | -1.43B | -1.82B | -1.25B | -855.22M | 3.29B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | ¥8.00B | 7.35 | 0.48% | 2.99% | 2.07% | ||
70 Neutral | ¥20.04B | 14.54 | 1.21% | 10.64% | 110.16% | ||
70 Neutral | ¥13.20B | 7.60 | 0.31% | 2.97% | -16.90% | ||
67 Neutral | ¥19.84B | 16.53 | 0.85% | -0.12% | 10.36% | ||
64 Neutral | $10.64B | 16.52 | 6.24% | 2.15% | 3.01% | -28.89% | |
60 Neutral | ¥45.77B | 13.33 | 2.57% | 1.10% | -29.92% | ||
58 Neutral | ¥2.99B | 25.83 | ― | 7.40% | 24.66% |